<http://webisa.webdatacommons.org/350307741>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/prov/422038060>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/350307741> .
<http://webisa.webdatacommons.org/prov/287311769>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/350307741> .
<http://webisa.webdatacommons.org/350307741>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<chestnet.org> .
<http://webisa.webdatacommons.org/350307741>	<http://www.w3.org/ns/prov#value>	"Levels of circulating proinflammatory cytokines and chemokines, such as tumor necrosis factor (TNF)-??, interleukin (IL)-6, and IL-8, are increased in patients with OSAS.8???9 In addition, OSAS induces the activation of adhesion molecules, including intercellular adhesion molecule (ICAM)-1, vascular cell adhesion molecule (VCAM)-1, and L-selectin.10Furthermore, platelet aggregation and activation" .